CTOs on the Move


 
Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management. Suvoda’s Interactive Response Technology (IRT/IWRS) combines the flexibility of a custom solution with the speed of a configurable platform, offering 4-week deployment, reimagined reporting, and easy integration.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.suvoda.com
  • 181 Washington Street Suite 100
    Conshohocken, PA USA 19428
  • Phone: 855.788.6321

Executives

Name Title Contact Details
Scot LeVan
Vice President of Global Information Technology Profile

Funding

Suvoda raised $40M on 12/05/2019

Similar Companies

Galleon Pharmaceutical

Galleon Pharmaceutical is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Orcabio

Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients` diseased blood and immune system with a healthy one.

Allen and Alice Stokes Nature

Allen and Alice Stokes Nature is a Logan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mental Health Partners

Mental Health Partners is Boulder and Broomfield Counties behavioral health center. Proudly serving our community for over 50 years. Get in. Get help. Get Better.

Deciphera

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known to be directly involved in the growth and spread of many cancers. We use our deep understanding of kinase biology together with a proprietary chemistry library to purposefully design compounds that maintain kinases in a “switched off” or inactivated conformation. Deciphera has developed a diverse pipeline of drug candidates designed to improve outcomes for patients with cancer by enhancing the quality, rate and/or durability of their responses to treatment.